71 related articles for article (PubMed ID: 11086960)
21. Phase I-II study of high-dose busulfan and cyclophosphamide followed by autologous peripheral blood stem cell transplantation for hematological malignancies: toxicities and hematopoietic recovery.
Ballester OF; Agaliotis DP; Hiemenz JW; Janssen WE; Fields KK; Zorksy PE; Goldstein SC; Perkins JB; Elfenbein GJ
Bone Marrow Transplant; 1996 Jul; 18(1):9-14. PubMed ID: 8831989
[TBL] [Abstract][Full Text] [Related]
22. [The role of proliferation and differentiation of the hematopoietic cell precursors during regeneration of hematopoiesis in cytostatic myelosuppression].
Dygaĭ AM; Zhdanov VV; Minakova MIu; Ryzhakov VM; Gol'dberg ED
Biull Eksp Biol Med; 1997 Dec; 124(12):616-20. PubMed ID: 9483310
[No Abstract] [Full Text] [Related]
23. [The role of SC-1(+)- and Thy-1(+)-cells in the regulation of cytokine production by cells of the bone marrow regenerating after cytostatic action].
Dygaĭ AM; Sherstoboev EIu; Gol'dberg ED
Biull Eksp Biol Med; 1998 Apr; 125(4):374-7. PubMed ID: 9631712
[No Abstract] [Full Text] [Related]
24. Reduction of hematotoxicity and augmentation of antitumor efficacy of cyclophosphamide by dopamine.
Lakshmi C; Deb C; Ray C; Ray MR
Neoplasma; 2005; 52(1):68-73. PubMed ID: 15739030
[TBL] [Abstract][Full Text] [Related]
25. [Reduction in hematotoxicity of chemotherapy using reinfusion of hematopoietic stem cells].
van Hoef ME
Ned Tijdschr Geneeskd; 1993 Jan; 137(5):240-4. PubMed ID: 8094541
[No Abstract] [Full Text] [Related]
26. [Establishment of a mouse model of cyclophosphamide-induced thrombocytopenia and determination of platelet function in this model].
Zhang Q; Peng HJ; Yu XB; Xu PL
Di Yi Jun Yi Da Xue Xue Bao; 2003 Dec; 23(12):1277-9, 1282. PubMed ID: 14678889
[TBL] [Abstract][Full Text] [Related]
27. [Appearance of foci of hematopoiesis and hematopoietic stem cells in the liver of mice following a single administration of cyclophosphane].
Barkhotkina MF; Repina FB; Svet-Moldavskaia IA
Biull Eksp Biol Med; 1975 Sep; 80(9):89-93. PubMed ID: 1222281
[TBL] [Abstract][Full Text] [Related]
28. Effect of cyclophosphamide on mouse bone marrow and leukemic stem cells.
Paprocka M; Budzyński W; Kuśnierczyk H; Radzikowski C
Arch Immunol Ther Exp (Warsz); 1980; 28(3):447-51. PubMed ID: 7447649
[TBL] [Abstract][Full Text] [Related]
29. [The effect of cyclophosphamide on the erythropoietic stem cell compartment].
Milenković P
Bilt Hematol Transfuz; 1980; 8(1):91-7. PubMed ID: 7337685
[TBL] [Abstract][Full Text] [Related]
30. [Influence of the combination of ionising radiation and cyclophosphamide on colony forming in hematopoietic stem cells].
Michailo W; Mitrov GG; Zographov DG
Strahlentherapie; 1972 Jul; 144(1):87-95. PubMed ID: 5080588
[No Abstract] [Full Text] [Related]
31. Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents.
Neben S; Hellman S; Montgomery M; Ferrara J; Mauch P
Exp Hematol; 1993 Jan; 21(1):156-62. PubMed ID: 8435103
[TBL] [Abstract][Full Text] [Related]
32. Double high-dose therapy for Hodgkin's disease with dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP) prior to high-dose melphalan and autologous stem cell transplantation.
Stewart DA; Guo D; Glück S; Morris D; Chaudhry A; deMetz C; Klassen J; Brown CB; Russell JA
Bone Marrow Transplant; 2000 Aug; 26(4):383-8. PubMed ID: 10982284
[TBL] [Abstract][Full Text] [Related]
33. Effect of two cyclophosphamide derivatives on hemopoietic progenitor cells and pluripotential stem cells.
Porcellini A; Manna A; Talevi N; Sparaventi G; Marchetti-Rossi MT; Baronciani D; De Biagi M
Exp Hematol; 1984 Dec; 12(11):863-6. PubMed ID: 6510485
[TBL] [Abstract][Full Text] [Related]
34. Interleukin 1 alpha (IL-1) and macrophage colony-stimulating factor (M-CSF) accelerate recovery from multiple drug-induced myelosuppression.
Kovacs CJ; Kerr JA; Daly BM; Evans MJ; Johnke RM
Anticancer Res; 1998; 18(3A):1805-12. PubMed ID: 9673408
[TBL] [Abstract][Full Text] [Related]
35. The effect of cyclophosphamide on hematopoietic stem cells.
Fried W; Johnson C
Radiat Res; 1968 Dec; 36(3):521-7. PubMed ID: 17387883
[TBL] [Abstract][Full Text] [Related]
36. Protective effects of IL-1 on human hematopoietic progenitor cells treated in vitro with 4-hydroperoxycyclophosphamide.
Moreb J; Zucali JR; Gross MA; Weiner RS
J Immunol; 1989 Mar; 142(6):1937-42. PubMed ID: 2784143
[TBL] [Abstract][Full Text] [Related]
37. Hematopoietic recovery after a single high dose of cyclophosphamide in the mouse.
Scaro JL; Barrio Rendo ME; Alvarez Prado de AR
Acta Physiol Lat Am; 1972; 22(4):258-65. PubMed ID: 4664105
[No Abstract] [Full Text] [Related]
38. Late effects of chemotherapy on hematopoietic progenitor cells.
Fried W; Adler S
Exp Hematol; 1985; 13 Suppl 16():49-56. PubMed ID: 3886419
[TBL] [Abstract][Full Text] [Related]
39. Bone marrow morphology during haematopoietic stem cell mobilisation with cyclophosphamide in mice.
Karbicka A; Marchlewicz M; Wiszniewska B; Machaliński B
Folia Morphol (Warsz); 2003 Nov; 62(4):435-7. PubMed ID: 14655135
[TBL] [Abstract][Full Text] [Related]
40. [Methods used for evaluating mutagenic and genotoxic properties of chemical compounds. I. The micronucleus test in vivo (an abridged version)].
Przybojewska B
Med Pr; 1988; 39(5):365-72. PubMed ID: 3151081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
